HIBio’s License Agreements with MorphoSys AG

Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys.HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR). Under…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now